SCHEMBL14930702

SCHEMBL14930702

C=CCOC(=O)[C@@H](C)CCCCNC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
PAOX Q6QHF9 3/20 0.39
TDP1 Q9NUW8 1/20 0.38
ADRA1A P35348 1/20 0.38
FOLH1 Q04609 1/20 0.38
MAPT P10636 3/20 0.34
CYP3A4 P08684 2/20 0.34
EPHX2 P34913 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
MTNR1A P48039 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19259278 0.84 KDM4E (0.43) KDM4EMAPK1HIF1APAOXTDP1
SCHEMBL13523926 0.82 MEN1 (0.50) KDM4ETDP1MAPTSMN1; SMN2
SCHEMBL19130730 0.81 BRD4 (0.38) TDP1MAPTALDH1A1TGM2
SCHEMBL16488804 0.80 TDP1 (0.41) KDM4ETDP1MAPTCYP3A4CYP2C9
SCHEMBL4957257 0.79 TSHR (0.54) TDP1TSHRALDH1A1HPGDZDHHC7
SCHEMBL9511070 0.79 MAPT (0.46) TDP1MAPTCYP3A4CYP2C9TSHR
SCHEMBL20663472 0.78 FAAH (0.38) TDP1FOLH1MAPTCYP3A4CYP2C9
SCHEMBL8260665 0.78 FAAH (0.38) TDP1FOLH1MAPTCYP3A4CYP2C9
SCHEMBL9508018 0.78 MAPT (0.48) TDP1MAPTCYP3A4CYP2C9TSHR
SCHEMBL7165375 0.78 TSHR (0.57) TDP1TSHRZDHHC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8734846-B2 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles BIND BIOSCIENCES, INC. (US) 2014-05-27 US disclosed
US-20130115192-A1 Methods for the Preparation of Targeting Agent Functionalized Diblock Copolymers for Use in Fabrication of Therapeutic Targeted Nanoparticles BIND BIOSCIENCES, INC (US) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130115192-A1 Methods for the Preparation of Targeting Agent Functionalized Diblock Copolymers for Use in Fabrication of Therapeutic Targeted Nanoparticles GNE, PAM, EPHA2 KDM4E 3536/4885MAPK1 4018/4885HIF1A 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.